Hematological and biochemical abnormalities among women with breast cancer

Background: Breast cancer is a complex and heterogeneous disease characterized by the abnormal proliferation of breast tissue, leading to tumor formation. It is the most common cancer diagnosis among women worldwide. Assessment of hematological and biochemical parameters can predict the severity, mortality, and follow-up treatment in women with breast cancer. The aim: The study aimed to evaluate hematological and biochemical parameters as useful markers among patients with breast cancer compared to healthy individuals. Methods: A total of 124 women diagnosed with breast cancer attended The Department of National Cancer Institute Sabratha (NCI), from November 2024 to March 2025, and 50 healthy controls from The Libyan Medical Centre at Zawia city were also involved in this study. Demographic and clinical data, including complete blood count, liver function, and kidney function, were obtained from these patients. Results: A significant decrease (P< 0.001) was observed in patients in terms of RBC HGB, HCT, MCV, and MCHC. On the other hand, platelet count (PLT) and lymphocytes were significantly higher in the patient groups than in controls (P